4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kwality Pharmaceuticals Limited (KPL) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Amritsar, India with about 1,137 employees. In the fiscal year ended 2026-03-31, KPL reported ₹5.0B in revenue and ₹674M in net income.
Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹5.0B | ₹3.7B | ₹3.1B | ₹2.5B | — |
| Gross Profit | ₹2.4B | ₹1.8B | ₹1.4B | ₹1.3B | — |
| Operating Income (EBIT) | ₹984M | ₹621M | ₹468M | ₹458M | — |
| Net Income | ₹674M | ₹398M | ₹238M | ₹194M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | ₹1.6B | ₹1.6B | ₹1.2B | ₹1.1B | ₹1.1B |
| Gross Profit | ₹749M | ₹704M | ₹643M | ₹564M | ₹534M |
| Operating Income (EBIT) | ₹360M | ₹335M | ₹251M | ₹204M | ₹194M |
| Net Income | ₹256M | ₹253M | ₹160M | ₹141M | ₹119M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹5.9B | ₹4.5B | ₹3.9B | ₹3.5B | — |
| Total Liabilities | ₹2.6B | ₹1.8B | ₹1.7B | ₹1.5B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KPL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms